Company intelligence / Profile preview

Apnex Medical

Saint Paul, Minnesota, United Statespmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Employees: ~3
Development stage: Phase 2

Overview

Apnex Medical developed an implantable hypoglossal nerve stimulation system for obstructive sleep apnea. The company raised over $50 million and advanced to a randomized clinical trial but shut down after disappointing early results indicated it was unlikely to meet its primary endpoint.[1] The device aimed to detect breathing patterns during sleep and stimulate the hypoglossal nerve to keep airways open.[5] No commercial approval was achieved.

Therapeutic areas: Pulmonology
Modalities: DeviceImplantable neurostimulation device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Apnex Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apnex Medical.

Explore the full profile